NORSK BOLIGUTVIKLING AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−1,9 mill kr).

NORSK BOLIGUTVIKLING AS is registered as a limited company in Senja, Troms with organisation number 912103862. The business is classified under development of building projects (NACE 68.120). The company was incorporated in 2013 and has 5 registered employees. Registered share capital is NOK 100,000, divided into 100 shares. The company's stated purpose is: “Kjøp og salg av fast eiendom, eiendomsutvikling samt ved aksjetegning eller på annen måte delta i annen virksomhet.”. The most recent filed accounts, for the 2025 financial year, show NOK 96.7m in revenue and NOK −1.9m in operating profit.

Key figures · 2025

Revenue

NOK 96.7m

▼ −61 %

Operating profit

NOK −1.9m

▼ −104 %

Equity

NOK 4.4m

▼ −59 %

Est. value

NOK 45.1m

Financial health · 2025

Liquidity

6.95

Very good

Current assets ÷ current liabilities

Profitability

-0.8%

Not satisfactory

Return on total assets

Solidity

3.3%

Weak

Equity as a share of total capital

Who owns NORSK BOLIGUTVIKLING AS?

CONSEPT EIENDOM AS Org. no. 984302053

100.0%

NORSK BOLIGUTVIKLING AS

NOK 96.7m rev. · NOK −1.9m profit

NORSK BOLIGUTVIKLING AS has 1 registered shareholder:

• CONSEPT EIENDOM AS 100.0%

All shareholders and roles →

Frequently asked questions about NORSK BOLIGUTVIKLING AS

Who owns NORSK BOLIGUTVIKLING AS?

CONSEPT EIENDOM AS is the largest registered owner, with 100.0%.

What is the revenue of NORSK BOLIGUTVIKLING AS?

NORSK BOLIGUTVIKLING AS had revenue of NOK 96.7m in 2025.

Who is the general manager of NORSK BOLIGUTVIKLING AS?

Torje Bårdsen is registered as general manager of NORSK BOLIGUTVIKLING AS.

Where is NORSK BOLIGUTVIKLING AS based?

NORSK BOLIGUTVIKLING AS has its business address in Finnsnes.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.